<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> FR89518-0030 </DOCNO><DOCID>fr.5-18-89.f2.A1029</DOCID><TEXT><ITAG tagnum="94"><ITAG tagnum="69"><ITAG tagnum="50">FEDERAL TRADE COMMISSION</ITAG><ITAG tagnum="52">16 CFR Part 13</ITAG><ITAG tagnum="41">[File No. 862 3125]</ITAG><ITAG tagnum="56">Nutritone, Inc., d/b/a Body By Design, et al.; Proposed Consent AgreementWith Analysis To Aid Public Comment</ITAG><ITAG tagnum="10"><T2>AGENCY: </T2>Federal Trade Commission.</ITAG><ITAG tagnum="10"><T2>ACTION: </T2>Proposed consent agreement.</ITAG><ITAG tagnum="10"><T2>SUMMARY: </T2>In settlement of alleged violations of federal law prohibitingunfair acts and practices and unfair methods of competition, this consentagreement, accepted subject to final Commission approval, would prohibit,among other things, a Massachusetts corporation from making certain claimsfor electric muscle stimulation (``EMS'') treatment programs and productsunless they possess reliable scientific evidence that substantiates suchclaims. Respondent would be required to retain records supporting any futureadvertising and also would be required to post a copy of the order on thepremises.</ITAG><ITAG tagnum="10"><T2>DATE: </T2>Comments must be received on or before July 17, 1989.</ITAG><ITAG tagnum="10"><T2>ADDRESS: </T2>Comments should be directed to: FTC/Office of the Secretary,Room 159, 6th St. and Pa. Ave., NW., Washington, DC 20580.</ITAG><ITAG tagnum="10"><T2>FOR FURTHER INFORMATION CONTACT: </T2>Phoebe Morse, Boston RegionalOffice, Federal Trade Commission, 10 Causeway St., Room 1184, Boston, Ma.02222-1073. (617) 565-7240.</ITAG><ITAG tagnum="10"><T2>SUPPLEMENTARY INFORMATION: </T2>Pursuant to section 6(f) of the FederalTrade Commission Act, 38 Stat. 721, 15 U.S.C. 46 and andSection; 2.34 ofthe Commission's Rules of Practice (16 CFR 2.34), notice is hereby giventhat the following consent agreement containing a consent order to ceaseand desist, having been filed with and accepted, subject to final approval,by the Commission, has been placed on the public record for a period ofsixty (60) days. Public comment is invited. Such comments or views willbe considered by the Commission and will be available for inspection andcopying at its principal office in accordance with andSection; 4.9(b)(6)(ii)of the Commission's Rules of Practice (16 CFR 4.9(b)(6)(ii).<ITAG tagnum="84">List of Subjects in 16 CFR Part 13</ITAG>Electric muscle stimulation treatments, Health clubs, Trade practices.<ITAG tagnum="21">In the matter of Nutritone, Inc., a corporation, trading and doingbusiness as BODY BY DESIGN, and Dinah H. Simonini, and Donald L. Simonini,individually, and as officers of the corporation</ITAG><ITAG tagnum="74">Agreement Containing Consent Order to Cease and Desist</ITAG>The Federal Trade Commission having initiated an investigation of certainacts and practices of Nutritone, Inc., a corporation, d/b/a Body By Design,and Dinah H. Simonini and Donald L. Simonini, individually and as officersof Nutritone, Inc., and it now appearing that Nutritone, Inc., and DinahH. Simonini and Donald L. Simonini, hereinafter sometimes referred to asproposed respondents, are willing to enter into an agreement containingan order to cease and desist from the use of the acts and practices beinginvestigated.<T3>It is hereby agreed </T3>by and between Nutritone, Inc., and DinahH. Simonini and Donald L. Simonini, individually and as officers of Nutritone,Inc., and their counsel, and counsel for the Federal Trade Commission that:1. Nutritone, Inc., hereinafter referred to as the corporation, is a corporationorganized existing and doing business under and by virtue of the laws ofthe Commonwealth of Massachusetts with its principal office and place ofbusiness at 1172 Beacon Street, Newton, Massachusetts 02161.  2. Proposed respondents Dinah H. Simonini and Donald L. Simonini are officersof the corporate respondent named herein. They have formulated, directedand controlled the acts and practices of the corporation, including allthe acts and practices set forth below. Their address is the same as thatof the corporate respondent.  3. Proposed respondents admit all the jurisdictional facts set forth inthe draft of the complaint here attached.  4. Proposed respondents waive:  a. Any further procedural steps;  b. The requirement that the Commission's decision contain a statement ofthe findings of fact and conclusions of law; and  c. All rights to seek judicial review or otherwise to challenge or contestthe validity of the order entered pursuant to this agreement.  d. All rights under the Equal Access to Justice Act.  5. This agreement shall not become part of the public record of the proceedingunless and until it is accepted by the Commission. If this agreement isaccepted by the Commission, it, together with the draft of complaint contemplatedthereby, will be placed on the public record for a period of sixty (60)days and information in respect thereto publicly released. The Commissionthereafter may either withdraw its acceptance of this agreement and sonotify the proposed respondents, in which event it will take such actionas it may consider appropriate, or issue and serve its complaint (in suchform as the circumstances may require) and decision, in disposition ofthe proceeding.  6. This agreement is for settlement purposes only and does not constitutean admission by proposed respondents that the law has been violated asalleged in the draft of complaint here attached.  7. This agreement contemplates that, if it is accepted by the Commission,and if such acceptance is not subsequently withdrawn by the Commissionpursuant to the provisions of andSection; 2.34 of the Commission's Rules,the Commission may, without further notice to proposed respondents, (1)issue its complaint corresponding in form and substance with the draftof complaint here attached and its decision containing the following orderto cease and desist in disposition of the proceeding and (2) make informationpublic in respect thereto. When so entered, the order to cease and desistshall have the same force and effect and may be altered, modified or setaside in the same manner and within the same time provided by statute forother orders. The order shall become final upon service. Delivery by theU.S. Postal Service of the complaint and decision containing the agreedto order to proposed respondents' address as stated in this agreement shallconstitute service. Proposed respondents waive any right they may haveto any other manner of service. The complaint may be used in construingthe terms of the order, and no agreement, understanding, representation,or interpretation not contained in the order or the agreement may be usedto vary or contradict the terms of the order.  8. Proposed respondents have read the proposed complaint and order contemplatedhereby. They understand that once the order has been issued, they willbe required to file one or more compliance reports showing that they fullycomplied with the order. Proposed respondents further understand that theymay be liable for civil penalties in the amount provided by law for eachviolation of the order after it becomes final.  <ITAG tagnum="84">Order  </ITAG>I.  <T3>It is ordered </T3>That respondents Nutritone, Inc., a corporation,its officers, and Dinah H. Simonini and Donald L. Simonini, individuallyand as officers of the corporation, their successors and assigns, and respondents'agents, representatives, and employees, directly or through any corporation,subsidiary, division or other device, in connection with the advertising,offering for sale, sale or distribution of any electric muscle stimulationtreatment program or product in or affecting commerce, as ``commerce''is defined in the Federal Trade Commission Act, do forthwith cease anddesist form representing, directly or by implication, contrary to fact,that any low frequency (1000 Hz and below) electric muscle stimulationtreatment or product:  A. Can cause muscle contractions of similar intensity to those producedby conventional exercise.  B. Will visibly change the girth of any part of the body without a reductionin caloric intake or participation in a weight loss program.C. Provides similar or superior health benefits to those produced by rigorousconventional exercise for normal healthy people. D. Provides, in the same or shorter time period, health benefits similaror superior to those produced by conventional exercise. E. Are a result of any new or recent scientific and technological researchand experimentation.II. <T3>It is further ordered </T3>That respondents Nutritone, Inc., a corporation,its officers, and Dinah H. Simonini and Donald L. Simonini, individuallyand as officers of the corporation, their successors and assigns, and respondents'agents, representatives, and employees, directly or through any corporation,subsidiary, division or other device, in connection with the advertising,offering for sale, sale or distribution of any diet, strength development,or fitness program or product in or affecting commerce, as ``commerce''is defined in the Federal Trade Commission Act, do forthwith cease anddesist from making any representation, directly or by implication, concerningsuch program's or product's efficacy, or comparability or superiority overany other program(s) or product(s), or the results typically achieved byany consumer(s) of the program or product unless, at the time of makingsuch representation respondents possess and rely upon competent and reliablescientific evidence that substantiates the representation; provided, however,that for purposes of this Order for any test, analysis, research, study,or other evidence to be ``competent and reliable'' it must be conductedand evaluated in an objective manner by persons qualified to do so, usingprocedures generally accepted in the profession to yield accurate and reliableresults.III. <T3>It is further ordered </T3>That resondents shall for at least fiveyears after the date of the last dissemination of the representation, maintainand upon reasonable request make available to the Federal Trade Commissionfor inspection and copying copies of: 1. All materials that were relied upon by respondents in disseminatingany representation covered by this order. 2. All test reports, studies, surveys, or demonstrations in their possessionor control that contradict any representation that is covered by this order.IV.  <T3>It is further ordered </T3>That respondents shall conspiciously posta copy of this order on their premises.V.  <T3>It is further ordered </T3>That the corporate respondent and the individualrespondents shall notify the Commission at least thirty (30) days priorto any proposed change in the corporate respondent such as dissolution,assignment, or sale resulting in the emergence of a successor corporation,the creation or dissolution of subsidaries or any other change in the corporationwhich may affect compliance obligations arising out of the order, or ofany change in the position or responsibilities of Dinah H. Simonini orDonald L.Simonini in regard to any corporation or subsidiary of which eitheris an officer and which corporation or subsidiary is, directly or indirectly,involved in the sale or distribution of any electric muscle stimulationtreatment program or product.VI. <T3>It is further ordered </T3>That the respondents shall, within sixty(60) days after service of this order, file with the Commission a report,in writing, setting forth in detail the manner and form in which they havecomplied with is order.<ITAG tagnum="84">Analysis of Proposed Consent Order to Aid Public Comment </ITAG>The Federal Trade Commission has accepted, subject to final approval, anagreement containing a consent order fromNutritone,Inc.,acorporation,  d/b/a Body By Design, and Dinah H. Simonini and Donald L. Simonini, officersof Nutritone, Inc. (collectively, the ``respondents''). Under this agreement,the respondents will cease and desist from making certain claims for treatmentprograms and products unless they possess reliable scientific evidencethat substantiates such claims. The proposed consent order has been placed on the public record for sixty(60) days for receipt of comments by interested persons. Comments receivedduring this period will become part of the public record. After sixty (60)days, the Commission will again review the agreement and the comments receivedand will decide whether it should withdraw from the agreement and takeother appropriate action or make final the proposed order contained inthe agreement. This matter concerns advertisements for electric muscle stimulation treatmentprograms and products. The Complaint accompanying the proposed consentorder alleges that, in connection with promoting these treatment programsand products, the respondents engaged in deceptive acts and practices inviolation of section 5 of the Federal Trade Commission Act and that therespondents disseminated false advertisements in violation of section 12of the Federal Trade Commission Act. According to the Complaint, the respondentsrepresented that these treatment programs and products would cause musclecontractions comparable to those resulting from conventional exercise suchas situps and pushups. They also claimed that the treatments would resultin a ``V'' shape for men and tone stomachs, thighs and buttocks, The Complaint also alleges that the advertisements were deceptive becausethe respondents represented to consumers that they possessed a reasonablebasis for the challenged representations when, in fact, respondents hadno reasonable basis for these representations. The consent order contains provisions designed to prevent the respondentsfrom engaging in similar allegedly illegal acts and practices in the future.Specifically, Part I of the order prohibits the respondents from representingthat any electric muscle stimulation treatment or product will: 1. Cause muscle contractions similar to those produced by exercise. 2. Will visibly change the girth or any part of the body without a reductionin caloric intake or participation in a weight loss program. 3. Provide similar or superior health benefits to those produced by rigorousconventional exercise. 4. Provide, in the same or shorter time period, health benefits similaror superior to those produced by conventional exercise. Part I also prohibitsrespondents from claiming that EMS treatments or products are the resultof any new or recent scientific and technological research and experimentation.Part II of the order prohibits the respondents from representing that anydiet, strength development, or fitness program or product will providecertain benefits or is comparable or superior to other programs or productsunless, at the time of making such representation, respondents possessand rely upon competent and reliable scientific evidence that substantiatesthe representation. Part III of the order requires the respondents to (1) retain records supportingany future advertising and (2) retain any records that contradict any suchadvertising. Part IV of the order requires the respondents to post a copy of the orderon the premises. Finally, Part V of the order requires the corporate respondent and theindividual respondents to give prior notification to the Federal TradeCommission of any changes or sale of the corporate respondent. The individualrespondents must also notify the Commission in the event they change positionsor responsibilities in any corporation that is involved in electric musclestimulation programs or products and in which either individual respondentis an officer. <ITAG tagnum="6">Donald S. Clark, </ITAG><ITAG tagnum="4">Secretary. </ITAG><ITAG tagnum="40">[FR Doc. 89-11947 Filed 5-17-89; 8:45 am] </ITAG><ITAG tagnum="68">BILLING CODE 6750-01-M </ITAG></ITAG></ITAG></ITAG></TEXT></DOC>